January 23-25, 2023
Hyatt Regency Austin
Austin, Texas

Please note that this Special Conference will take place as an in-person event in Austin and will not live-stream content for virtual participation. The program content will be captured and made available as an on-demand program after the conference. Additional information will be available later this year.

CONFERENCE COCHAIRS

Ravi Majeti, Stanford University, Stanford, California
Maria (Ken) Figueroa, University of Miami, Miami, Florida
Ruben Mesa, Mays Cancer Center at UT Health San Antonio, San Antonio, Texas

This special conference will be the first AACR event to focus specifically on myeloid malignancies, namely myelodysplastic syndrome and acute myeloid leukemia. Anchored in presentations by leading experts in the field, this conference will cover the latest research efforts in minimal residual disease, splicing mutations, cell and immune targeting in myeloid malignancies, apoptosis, stem cells, epigenetics, inflammation, the niche/microenvironment, and more. Poster sessions will allow for presentation of the work in submitted abstracts by attendees. The program will be presented in person with post-event on-demand registration available for those that cannot attend in-person.

AACR Statement Regarding Venues for the 2023 Annual Meeting and Other Conferences

The AACR released a statement regarding the venues for the 2023 Annual Meeting and its other conferences in response to recent legislative and political decisions at the state level that may not align with our values.

Read the Statement

Supporter

Syros Pharmaceuticals Inc.

#aacrAMLMDS

Continuing Medical Education Activity AMA PRA Category 1 Credits^TM available